Alzheimer's Association: The Tau Pipeline Enabling Program (T-PEP)- (LOI)

Seeks to accelerate the discovery of potential new therapies for tauopathies. The intent of this program is to enrich the pipeline for therapy development by facilitating the translation of academia derived ideas into practical application.

Funding: $750K for 2 years.

(Direct and indirect costs- indirect costs 10%)

Please contact the research authority if planning to submit- nonprofit.

https://www.alz.org/research/alzheimers_grants/T-PEP.asp#deadlines